Improving Care Through Azithromycin Research for Infants in Africa

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

20,560

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

September 11, 2025

Study Completion Date

April 30, 2026

Conditions
Child Mortality
Interventions
DRUG

Azithromycin

Administration of azithromycin during the first 15 months of life through the Expanded Program on Immunisation

DRUG

Placebo

Administration of placebo during the first 15 months of life through the Expanded Program on Immunisation

Trial Locations (1)

Unknown

College of Medicine and Allied Health Sciences, Freetown

All Listed Sponsors
collaborator

University of Sierra Leone

OTHER

collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Ministry of Health and Sanitation, Sierra Leone

OTHER_GOV

collaborator

La Caixa Foundation

OTHER

lead

Barcelona Institute for Global Health

OTHER